Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;13(4):451-462.
doi: 10.1007/s12079-018-00500-8. Epub 2019 Jan 3.

Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations

Affiliations

Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations

Yousof Taghavi et al. J Cell Commun Signal. 2019 Dec.

Abstract

Diabetic retinopathy (DR) is considered as a diabetes-related complication that can render severe visual impairments and is also a risk factor for acquired blindness in both developed as well as developing countries. Through fibrovascular epiretinal membranes (ERMs), this condition can similarly lead to tractional retinal detachment. Laboratory efforts evaluating the DR pathogenesis can be provided by ocular vitreous fluid and ERMs resulting from vitrectomy. The clinical stages of DR are significantly associated with expression levels of certain chemokines, including monocyte chemotactic protein-1 (MCP-1) in the intraocular fluid. The MCP-1 is also a known potent chemotactic factor for monocytes and macrophages that can stimulate them to produce superoxide and other mediators. Following hyperglycemia, retinal pigmented epithelial (RPE) cells, endothelial cells, and Müller's glial cells are of utmost importance for MCP-1 production, and vitreous MCP-1 levels rise in patients with DR. Increased expression of the MCP-1 in the eyes can also play a significant role in the pathogenesis of DR. In this review, current clinical and laboratory progress achieved on the MCP-1 and the DR concerning neovascularization and inflammatory responses in vitreous and/or aqueous humor of DR patients was summarized. It was suggested that further exploration of the MCP-1/CCR2 axis association between clinical stages of DR and expression levels of inflammatory and angiogenic cytokines and chemokines, principally the MCP-1 might lead to potential therapies aiming at neutralizing antibodies and viral vectors.

Keywords: CCL2; DR; MCP-1; PDR; Retinopathy.

PubMed Disclaimer

Conflict of interest statement

All of the authors declared no conflict of interest.

Figures

Fig. 1
Fig. 1
Involvement of RPE cells, Müller cells in the production of MCP-1 in the retinal inflammation, vascular permeability, and neovascularization following hyperglycemia and diabetes in DR patients. In addition, MCP-1 is the main factor in the recruitment of monocytes and macrophages into the retina, and these type of cells are responsible for ROS production and inflammation. ROS: reactive oxygen species; MCP-1: monocyte chemotactic protein-1; RPE cell: retinal pigment epithelium cell

Similar articles

Cited by

References

    1. Abcouwer SF (2013) Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol 1(11):1–12 - PMC - PubMed
    1. Adamis A P. Is diabetic retinopathy an inflammatory disease? British Journal of Ophthalmology. 2002;86(4):363–365. - PMC - PubMed
    1. Adamis AP, Berman AJ (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Seminars in immunopathology. Springer - PubMed
    1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–1487. - PubMed
    1. Antunica AG, Karaman K, Znaor L, Sapunar A, Buško V, Puzović V. IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol. 2012;250(6):815–821. - PubMed